Literature DB >> 17027056

Mutagenesis of the La Crosse Virus glycoprotein supports a role for Gc (1066-1087) as the fusion peptide.

Matthew L Plassmeyer1, Samantha S Soldan, Karen M Stachelek, Susan M Roth, Julio Martín-García, Francisco González-Scarano.   

Abstract

The La Crosse Virus (LACV) M segment encodes two glycoproteins (Gn and Gc), and plays a critical role in the neuropathogenesis of LACV infection as the primary determinant of neuroinvasion. A recent study from our group demonstrated that the region comprising the membrane proximal two-thirds of Gc, amino acids 860-1442, is critical in mediating LACV fusion and entry. Furthermore, computational analysis identified structural similarities between a portion of this region, amino acids 970-1350, and the E1 fusion protein of two alphaviruses: Sindbis virus and Semliki Forrest virus (SFV). Within the region 970-1350, a 22-amino-acid hydrophobic segment (1066-1087) is predicted to correlate structurally with the fusion peptides of class II fusion proteins. We performed site-directed mutagenesis of key amino acids in this 22-amino acid segment and determined the functional consequences of these mutations on fusion and entry. Several mutations within this hydrophobic domain affected glycoprotein expression to some extent, but all mutations either shifted the pH threshold of fusion below that of the wild-type protein, reduced fusion efficiency, or abrogated cell-to-cell fusion and pseudotype entry altogether. These results, coupled with the aforementioned computational modeling, suggest that the LACV Gc functions as a class II fusion protein and support a role for the region Gc 1066-1087 as a fusion peptide.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17027056      PMCID: PMC1820767          DOI: 10.1016/j.virol.2006.08.050

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  53 in total

1.  Enzyme processing of La Crosse virus glycoprotein G1: a bunyavirus-vector infection model.

Authors:  G V Ludwig; B M Christensen; T M Yuill; K T Schultz
Journal:  Virology       Date:  1989-07       Impact factor: 3.616

2.  Efficient selection for high-expression transfectants with a novel eukaryotic vector.

Authors:  H Niwa; K Yamamura; J Miyazaki
Journal:  Gene       Date:  1991-12-15       Impact factor: 3.688

3.  Murine leukemia virus pseudotypes of La Crosse and Hantaan Bunyaviruses: a system for analysis of cell tropism.

Authors:  M Ma; D B Kersten; K I Kamrud; R J Wool-Lewis; C Schmaljohn; F González-Scarano
Journal:  Virus Res       Date:  1999-10       Impact factor: 3.303

4.  Mechanisms of bunyavirus virulence. Comparative pathogenesis of a virulent strain of La Crosse and an avirulent strain of Tahyna virus.

Authors:  R Janssen; F Gonzalez-Scarano; N Nathanson
Journal:  Lab Invest       Date:  1984-04       Impact factor: 5.662

5.  Localization of Bunyamwera bunyavirus G1 glycoprotein to the Golgi requires association with G2 but not with NSm.

Authors:  D F Lappin; G W Nakitare; J W Palfreyman; R M Elliott
Journal:  J Gen Virol       Date:  1994-12       Impact factor: 3.891

6.  An avirulent G1 glycoprotein variant of La Crosse bunyavirus with defective fusion function.

Authors:  F Gonzalez-Scarano; R S Janssen; J A Najjar; N Pobjecky; N Nathanson
Journal:  J Virol       Date:  1985-06       Impact factor: 5.103

7.  La Crosse bunyavirus can mediate pH-dependent fusion from without.

Authors:  F Gonzalez-Scarano; N Pobjecky; N Nathanson
Journal:  Virology       Date:  1984-01-15       Impact factor: 3.616

8.  Conserved glycine residues in the fusion peptide of the paramyxovirus fusion protein regulate activation of the native state.

Authors:  Charles J Russell; Theodore S Jardetzky; Robert A Lamb
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

9.  A fusion-defective mutant of the vesicular stomatitis virus glycoprotein.

Authors:  M A Whitt; P Zagouras; B Crise; J K Rose
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

10.  Interaction with CD4 and antibodies to CD4-induced epitopes of the envelope gp120 from a microglial cell-adapted human immunodeficiency virus type 1 isolate.

Authors:  Julio Martín-García; Simon Cocklin; Irwin M Chaiken; Francisco González-Scarano
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

View more
  30 in total

1.  Genetic characterization of the Wyeomyia group of orthobunyaviruses and their phylogenetic relationships.

Authors:  Rashmi Chowdhary; Craig Street; Amelia Travassos da Rosa; Marcio R T Nunes; Kok Keng Tee; Stephen K Hutchison; Pedro F C Vasconcelos; Robert B Tesh; W Ian Lipkin; Thomas Briese
Journal:  J Gen Virol       Date:  2012-01-25       Impact factor: 3.891

2.  Insights into bunyavirus architecture from electron cryotomography of Uukuniemi virus.

Authors:  A K Overby; R F Pettersson; K Grünewald; J T Huiskonen
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-12       Impact factor: 11.205

3.  Orthobunyavirus entry into neurons and other mammalian cells occurs via clathrin-mediated endocytosis and requires trafficking into early endosomes.

Authors:  Bradley S Hollidge; Natalia B Nedelsky; Mary-Virginia Salzano; Jonathan W Fraser; Francisco González-Scarano; Samantha S Soldan
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

4.  La Crosse virus (LACV) Gc fusion peptide mutants have impaired growth and fusion phenotypes, but remain neurotoxic.

Authors:  Samantha S Soldan; Bradley S Hollidge; Valentina Wagner; Friedemann Weber; Francisco González-Scarano
Journal:  Virology       Date:  2010-05-31       Impact factor: 3.616

5.  Genomic and phylogenetic characterization of Leanyer virus, a novel orthobunyavirus isolated in northern Australia.

Authors:  Nazir Savji; Gustavo Palacios; Amelia Travassos da Rosa; Stephen Hutchison; Christopher Celone; Jeffrey Hui; Thomas Briese; Charles H Calisher; Robert B Tesh; W Ian Lipkin
Journal:  J Gen Virol       Date:  2011-03-14       Impact factor: 3.891

6.  Acid-activated structural reorganization of the Rift Valley fever virus Gc fusion protein.

Authors:  S M de Boer; J Kortekaas; L Spel; P J M Rottier; R J M Moormann; B J Bosch
Journal:  J Virol       Date:  2012-10-03       Impact factor: 5.103

7.  Severe fever with thrombocytopenia virus glycoproteins are targeted by neutralizing antibodies and can use DC-SIGN as a receptor for pH-dependent entry into human and animal cell lines.

Authors:  Heike Hofmann; Xingxing Li; Xiaoai Zhang; Wei Liu; Annika Kühl; Franziska Kaup; Samantha S Soldan; Francisco González-Scarano; Friedemann Weber; Yuxian He; Stefan Pöhlmann
Journal:  J Virol       Date:  2013-02-06       Impact factor: 5.103

8.  Prevalence and protein specificity of human antibodies to Inkoo virus infection.

Authors:  Niina Putkuri; Antti Vaheri; Olli Vapalahti
Journal:  Clin Vaccine Immunol       Date:  2007-10-17

9.  Discovery of a unique novel clade of mosquito-associated bunyaviruses.

Authors:  Marco Marklewitz; Florian Zirkel; Innocent B Rwego; Hanna Heidemann; Pascal Trippner; Andreas Kurth; René Kallies; Thomas Briese; W Ian Lipkin; Christian Drosten; Thomas R Gillespie; Sandra Junglen
Journal:  J Virol       Date:  2013-09-25       Impact factor: 5.103

10.  Functional analysis of the Bunyamwera orthobunyavirus Gc glycoprotein.

Authors:  Xiaohong Shi; Josthna Goli; Gordon Clark; Kristina Brauburger; Richard M Elliott
Journal:  J Gen Virol       Date:  2009-07-01       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.